These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 8607396)

  • 21. Flecainide acetate in the treatment of supraventricular tachycardias: value of programmed electrical stimulation for long-term prognosis.
    van Wijk LM; Crijns HJ; van Gilst WH; Wesseling H; Lie KI
    Am Heart J; 1989 Feb; 117(2):365-9. PubMed ID: 2492738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flecainide acetate for treatment of bypass tract mediated reentrant tachycardia.
    Zee-Cheng CS; Kim SS; Ruffy R
    Am J Cardiol; 1988 Aug; 62(6):23D-28D. PubMed ID: 3136631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flecainide acetate treatment of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation: dose-response studies. The Flecainide Supraventricular Tachycardia Study Group.
    Pritchett EL; DaTorre SD; Platt ML; McCarville SE; Hougham AJ
    J Am Coll Cardiol; 1991 Feb; 17(2):297-303. PubMed ID: 1899432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanisms.
    Katritsis D; Rowland E; O'Nunain S; Shakespeare CF; Poloniecki J; Camm AJ
    Eur Heart J; 1995 Dec; 16(12):1930-5. PubMed ID: 8682029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term efficacy and safety of beta-adrenergic receptor antagonists for supraventricular tachycardia.
    Lindsay BD; Saksena S; Rothbart ST; Herman S; Barr MJ
    Am J Cardiol; 1987 Aug; 60(6):63D-67D. PubMed ID: 2888301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia.
    Gambhir DS; Bhargava M; Arora R; Khalilullah M
    Indian Heart J; 1995; 47(3):237-43. PubMed ID: 7558090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of oral flecainide and amiodarone for the treatment of recurrent supraventricular tachycardia in children.
    Hill AC; Silka MJ; Bar-Cohen Y
    Pacing Clin Electrophysiol; 2019 Jun; 42(6):670-677. PubMed ID: 30875081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias.
    Hohnloser SH; Zabel M
    Am J Cardiol; 1992 Aug; 70(5):3A-9A; discussion 9A-10A. PubMed ID: 1387287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group.
    Aliot E; Denjoy I
    Am J Cardiol; 1996 Jan; 77(3):66A-71A. PubMed ID: 8607394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the electrophysiologic effects of oral sustained-release and intravenous verapamil in patients with paroxysmal supraventricular tachycardia.
    Lai WT; Voon WC; Yen HW; Chang JS; Sheu SH; Hwang YS; Chiu HF
    Am J Cardiol; 1993 Feb; 71(5):405-8. PubMed ID: 8430627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flecainide for supraventricular tachycardia in children.
    Zeigler V; Gillette PC; Hammill B; Ross BA; Ewing L
    Am J Cardiol; 1988 Aug; 62(6):41D-43D. PubMed ID: 3136635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flecainide therapy in patients treated for supraventricular tachycardia with near normal left ventricular function.
    Hughes MM; Trohman RG; Simmons TW; Castle LW; Wilkoff BL; Morant VA; Maloney JD
    Am Heart J; 1992 Feb; 123(2):408-12. PubMed ID: 1736577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia.
    Alboni P; Tomasi C; Menozzi C; Bottoni N; Paparella N; Fucà G; Brignole M; Cappato R
    J Am Coll Cardiol; 2001 Feb; 37(2):548-53. PubMed ID: 11216977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous flecainide acetate for the clinical management of paroxysmal tachycardias.
    Nathan AW; Camm AJ; Bexton RS; Hellestrand KJ
    Clin Cardiol; 1987 May; 10(5):317-22. PubMed ID: 3109795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of oral flecainide acetate in patients with cardiac arrhythmias.
    Nakazato Y; Nakata Y; Yasuda M; Nakazato K; Sumiyoshi M; Ogura S; Yamaguchi H
    Jpn Heart J; 1997 May; 38(3):379-85. PubMed ID: 9290572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Catheter ablation in supraventricular tachycardia].
    Pitschner HF; Neuzner J
    Z Kardiol; 1996; 85 Suppl 6():45-60. PubMed ID: 9064982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flecainide and sotalol: a new combination therapy for refractory supraventricular tachycardia in children <1 year of age.
    Price JF; Kertesz NJ; Snyder CS; Friedman RA; Fenrich AL
    J Am Coll Cardiol; 2002 Feb; 39(3):517-20. PubMed ID: 11823091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrophysiologic effects and antiarrhythmic efficacy of recainam in patients with supraventricular tachycardia.
    Tai YT; Campbell RW; McComb JM
    J Cardiovasc Pharmacol; 1991 Feb; 17(2):310-5. PubMed ID: 1709237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Electrophysiological effects and clinical efficacy of flecainide in childhood patients with supraventricular reciprocating paroxysmal tachycardia].
    Musto B; D'Onofrio A; Cavallaro C; Musto A; Della Gatta O; Marsico F
    G Ital Cardiol; 1987 May; 17(5):444-9. PubMed ID: 3115857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of intravenous sotalol for suppressing inducibility of supraventricular tachycardias at rest and during isometric exercise.
    Huikuri HV; Koistinen MJ; Takkunen JT
    Am J Cardiol; 1992 Feb; 69(5):498-502. PubMed ID: 1736614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.